Institution
University of Roehampton
Education•London, United Kingdom•
About: University of Roehampton is a education organization based out in London, United Kingdom. It is known for research contribution in the topics: Context (language use) & Population. The organization has 1716 authors who have published 4433 publications receiving 98183 citations. The organization is also known as: Roehampton University.
Topics: Context (language use), Population, Politics, Higher education, Anxiety
Papers published on a yearly basis
Papers
More filters
•
TL;DR: Brand experience is conceptualized as sensations, feelings, cognitions, and behavioral responses evoked by brand-related stimuli that are part of a brand's design and identity, packaging, communications, and environments.
Abstract: Brand experience is conceptualized as sensations, feelings, cognitions, and behavioral responses evoked by brand-related stimuli that are part of a brand's design and identity, packaging, communications, and environments. The authors distinguish several experience dimensions and construct a brand experience scale that includes four dimensions: sensory, affective, intellectual, and behavioral. In six studies, the authors show that the scale is reliable, valid, and distinct from other brand measures, including brand evaluations, brand involvement, brand attachment, customer delight, and brand personality. Moreover, brand experience affects consumer satisfaction and loyalty directly and indirectly through brand personality associations.
2,671 citations
••
Jagiellonian University1, University of Glasgow2, Queen Mary University of London3, Vanderbilt University Medical Center4, University of Manchester5, University of Naples Federico II6, University of Roehampton7, University of Texas at Austin8, Jagiellonian University Medical College9, Humboldt University of Berlin10, Huazhong University of Science and Technology11, Catholic University of the Sacred Heart12
TL;DR: While ACE2 is essential for viral invasion, there is no evidence that ACE inhibitors or angiotensin receptor blockers (ARBs) worsen prognosis, Hence, patients should not discontinue their use.
Abstract: The novel coronavirus disease (COVID-19) outbreak, caused by SARS-CoV-2, represents the greatest medical challenge in decades. We provide a comprehensive review of the clinical course of COVID-19, its comorbidities, and mechanistic considerations for future therapies. While COVID-19 primarily affects the lungs, causing interstitial pneumonitis and severe acute respiratory distress syndrome (ARDS), it also affects multiple organs, particularly the cardiovascular system. Risk of severe infection and mortality increase with advancing age and male sex. Mortality is increased by comorbidities: cardiovascular disease, hypertension, diabetes, chronic pulmonary disease, and cancer. The most common complications include arrhythmia (atrial fibrillation, ventricular tachyarrhythmia, and ventricular fibrillation), cardiac injury [elevated highly sensitive troponin I (hs-cTnI) and creatine kinase (CK) levels], fulminant myocarditis, heart failure, pulmonary embolism, and disseminated intravascular coagulation (DIC). Mechanistically, SARS-CoV-2, following proteolytic cleavage of its S protein by a serine protease, binds to the transmembrane angiotensin-converting enzyme 2 (ACE2) -a homologue of ACE-to enter type 2 pneumocytes, macrophages, perivascular pericytes, and cardiomyocytes. This may lead to myocardial dysfunction and damage, endothelial dysfunction, microvascular dysfunction, plaque instability, and myocardial infarction (MI). While ACE2 is essential for viral invasion, there is no evidence that ACE inhibitors or angiotensin receptor blockers (ARBs) worsen prognosis. Hence, patients should not discontinue their use. Moreover, renin-angiotensin-aldosterone system (RAAS) inhibitors might be beneficial in COVID-19. Initial immune and inflammatory responses induce a severe cytokine storm [interleukin (IL)-6, IL-7, IL-22, IL-17, etc.] during the rapid progression phase of COVID-19. Early evaluation and continued monitoring of cardiac damage (cTnI and NT-proBNP) and coagulation (D-dimer) after hospitalization may identify patients with cardiac injury and predict COVID-19 complications. Preventive measures (social distancing and social isolation) also increase cardiovascular risk. Cardiovascular considerations of therapies currently used, including remdesivir, chloroquine, hydroxychloroquine, tocilizumab, ribavirin, interferons, and lopinavir/ritonavir, as well as experimental therapies, such as human recombinant ACE2 (rhACE2), are discussed.
1,060 citations
••
TL;DR: Behavioural interventions, focusing on early life exposure, could be developed to attenuate food neophobia and 'picky/fussy' eating in children, so promoting the ready acceptance and independent choice of fruits and vegetables.
916 citations
••
TL;DR: It is shown that female preference for secondary sexual traits in male face shapes varies with the probability of conception across the menstrual cycle, similar to that of men with low fluctuating asymmetry.
Abstract: Women prefer slightly feminized male facial shapes1. Such faces (Fig. 1a) are given positive personality attributions1 that might correlate with actual behaviour2. In contrast, masculine features seem to signal immunological competence3. Heritable benefits can be realized only if conception follows copulation, so women might be more attentive to phenotypic markers indicating immunological competence during the follicular phase of the menstrual cycle when conception is most likely4,5. Consistent with this hypothesis is the observation that women's preference for the odour of men with low fluctuating asymmetry (a correlate of testosterone-facilitated trait size and developmental stability) increases with the probability of conception across the menstrual cycle5.Symmetrical men report more extra-pair copulation partners6, and extra-pair copulation rates peak in midcycle7. Here we show that female preference for secondary sexual traits in male face shapes varies with the probability of conception across the menstrual cycle.
807 citations
••
TL;DR: The traits showed predicted associations with sensation seeking and the Big Five personality dimensions, supporting the construct validity of the measure of callous-unemotional traits.
Abstract: This study examined the structure, distribution, and correlates of a new measure of self-reported callous-unemotional (CU) traits in 1,443 adolescents (774 boys, 669 girls) between the ages of 13 to 18 years. The Inventory of Callous-Unemotional Traits was subjected to exploratory factor analysis and confirmatory factor analysis. Exploratory factor analysis produced three factors: callousness, uncaring, and unemotional. Fit indexes suggested that the three-factor model, with a single higher-order factor, represented a satisfactory solution for the data. This factor structure fits well for both boys and girls. CU traits correlated significantly with measures of conduct problems and psychosocial impairment. Furthermore, the traits showed predicted associations with sensation seeking and the Big Five personality dimensions, supporting the construct validity of the measure of CU traits.
796 citations
Authors
Showing all 1771 results
Name | H-index | Papers | Citations |
---|---|---|---|
Robert R. Edelman | 119 | 605 | 49475 |
Christopher H. Evans | 104 | 717 | 42371 |
Thomas H. Ollendick | 85 | 507 | 30504 |
Andrea Kübler | 77 | 271 | 20965 |
Michael W. Eysenck | 64 | 204 | 23417 |
David J. Hargreaves | 61 | 257 | 13729 |
Michael Watts | 55 | 264 | 15176 |
Paul Allen | 55 | 206 | 12141 |
Kate E. Jones | 52 | 145 | 19569 |
Ron Pinhasi | 49 | 180 | 10106 |
Claus Vögele | 48 | 241 | 6557 |
Alexander M. Milner | 47 | 124 | 6290 |
Becky Francis | 46 | 118 | 5942 |
Cecilia A. Essau | 45 | 196 | 8053 |
Jane Broadbent | 44 | 113 | 6789 |